A previously defined immunoglobulin M(K) monoclonal antibody reacting with a surface epitope of Mycoplasma hyorhinis is shown in this report to mediate specific, complement-dependent mycoplasmacidal activity. Immunoblot analysis of mycoplasma components and their tryptic cleavage products showed that the epitope recognized was present on a protein with an apparent molecular weight of 23,000 (p23) and on a limit tryptic fragment of this protein with an apparent molecular weight of 18,000 (p18). Both p23 and p18 are shown by Triton X-114 phase fractionation to partition efficiently into the hydrophobic detergent phase. Other antigens bearing epitopes not expressed at the cell surface were present among the numerous hydrophilic proteins found in the aqueous phase. The external orientation and membrane association of the p23 antigen were further established by demonstrating that trypsin treatment of intact mycoplasmas generated the antigenic p18 fragment, which remained tightly associated with the organism. These results localize an epitope responsible for antibody-mediated mycoplasma killing onto a specific, surface-exposed region of an integral membrane protein of this organism. Since the monoclonal antibody used in this study does not bind to the surface of all strains of M. hyorhinis, the epitope identified also defines a structural marker of antigenic surface variation within this species, a feature previously observed during serological classification of the organism. Analysis of the antigenic and structural features of the p23 surface antigen may therefore be useful in establishing mechanisms of surface antigen variation among integral membrane proteins of mycoplasmas that could dictate important antigenic characteristics recognized during chronic disease caused by these agents.
Mycoplasma hyorhinis (2) is an etiologic agent causing chronic polyarthritis in swine (21, 27) and is a common contaminant of cell cultures maintained in vitro in many laboratories (9) . In both circumstances, the external surface of the single, limiting mycoplasma membrane figures prominently in dictating the interaction of these cell surface parasites with the host. First, the physical juxtaposition of the mycoplasma membrane with that of the host cell must be mediated in part by surface membrane structures. Second, the immunological response to mycoplasma surface components may be important either in controlling or exacerbating chronic mycoplasmal disease by a number of mechanisms previously considered elsewhere (3, 4, 8, 28, 29) .
Analysis of antigens by specific antibodies (and in some cases monoclonal antibodies [MAbs] ) has been useful in defining potentially important surface structures of some mycoplasma species (10, 14, 26) ; this includes the initial characterization of M. hyorhinis surface components in our own laboratory (31, 32) and by others (13) . Elucidation of mycoplasma surface antigen structure is also important in light of the implied involvement of surface antigens in antibody-mediated metabolic and growth inhibition tests, which are widely used to classify mycoplasma species (11, 24) . The characterization of surface structures defining these serological specificities has been established in remarkably few cases (26) , although the probable importance of these antigens in the host response to mycoplasma infection has been discussed (15, 19, 26) . Moreover, in some species displaying marked antigenic variation in these serological assays, including M. hyorhinis (12, 27) , the characterization of the molecules involved could lead to a general under-* Corresponding author.
standing of the structural basis of intraspecies surface antigenic variation among mycoplasmas. Particularly relevant structural features of these molecules pertinent to this question are the location of the epitopes recognized and the nature of the interaction between the antigen and the mycoplasma plasma membrane.
Using an MAb previously reported to react with a protein on the surface of M. hyorhinis (31) , we further investigate in this report the ability of the antibody to mediate complement-dependent killing of these organisms. A detergent phase partitioning system is applied for the isolation of the corresponding antigen; this system may be of general use in fractionating and analyzing integral surface membrane proteins of mycoplasmas. Localization of the epitope recognized by the monoclonal antibody onto a hydrophobic proteolytic fragment is also reported, and the selective expression of this epitope on some strains of M. hyorhinis is considered in defining this novel antigenic structure associated with surface antigenic variation within this species.
MATERIALS AND METHODS
Mycoplasma stocks and cultures. M. hyorhinis GDL was obtained from Richard Ross and has been described previously (29, 32) . Mycoplasmas were cultured in spinner flasks at 37°C with a previously described modified Hayflick broth medium (32) containing 20% (vol/vol) fetal bovine serum (Hazelton Dutchland, Inc., Denver, Pa.) or horse serum (Dutchland) heat inactivated and preselected for low mycoplasmacidal activity in the presence of complement.
Logarithmic-phase cultures were used directly for mycoplasmacidal assays. Mycoplasma stocks for immunoblotting and phase partitioning were prepared by sedimenting organisms from broth cultures. Logarithmic-phase cultures were PHASE FRACTIONATION OF MYCOPLASMA MEMBRANE ANTIGENS 1095 centrifuged for 10 min at 500 x g to remove debris, and the resulting supernatant was centrifuged for 10 min at 19,000 x g to sediment mycoplasmas. Pellets were rinsed by suspension in phosphate-buffered saline (PBS; 2.7 mM KCl, 1.5 mM KH2PO4, 137 mM NaCl, 8.0 mM Na2HPO4, pH 7.2) and centrifuged, and the final pellet was suspended in PBS for storage at -70°C.
Intact mycoplasmas were prepared by isopycnic sedimentation of organisms from broth culture onto linear 0 to 40% metrizamide (Accurate Chemical and Scientific Corp., Hicksville, N.Y.) gradients, as described in detail elsewhere (30) . The turbid band of organisms was collected from gradients with a Pasteur pipette, diluted and mixed with 2 volumes of PBS, and centrifuged at 4°C for 5 min at 13,000 x g. Peileted organisms were suspended in PBS and used immediately for experiments involving trypsin treatment of intact organisms. Recovery of viable mycoplasmas by this method was determined to be over 95% by measuring infectivity in a limit dilution assay of metabolic activity and by titration of CFU (20, 29) .
MAbs. The production and characterization of MAbs to M. hyorhinis antigens p23 and p17 (p23/17) (F20C17F), p51 (F81C39R), and p38 (F24C4Fg) have been described in detail elsewhere (31, 32 (33) .
Hybridoma culture fluid supematants containing MAbs were used as described previously (27) for immunoblotting procedures. Ammonium sulfate-precipitated and dialyzed culture fluids were prepared as described previously (32, 33) and used for mycoplasmacidal assays.
Complement-dependent mycoplasmacidal assay. To assess the mycoplasmacidal effects of MAbs, the following components were mixed and allowed to react for 2 h at 37°C: (i) 100 ,ul of a logarithmic-phase mycoplasma culture diluted in broth medium to 2.5 x 104 CFU/ml (titer determined as described above), (ii) (16) , with 9 to 14% acrylamide linear gradient gels as described previously (32) .
Electrophoretic transfer of separated components to nitrocellulose filters and subsequent immunological staining were performed by modifications of the method of Towbin et al. (25) , as previously described (32) .
Phase fractionation of epitope-bearing tryptic digestion products from disrupted mycoplasmas. Frozen mycoplasma stocks were thawed and suspended to 2.0 mg of protein per ml in PBS; trypsin (type XII; Sigma) was added to a final concentration of 1.0 mg/ml, and the suspension was allowed to incubate at 37°C for 30 min with occasional mixing. The protease inhibitor phenylmethylsulfonyl fluoride was then added to a final concentration of 1 mM, and the samples were pelleted at 4°C for 10 min at 13,000 x g. The pellet was suspended to the original volume in PBS containing 1 mM phenylmethylsulfonyl fluoride, and TX-114 phase partitioning was carried out as described above.
In some experiments, similar preparations containing trypsin-treated or untreated membranes were incubated with reagents to release peripherally associated membrane components. Disrupted mycoplasmas isolated as described above were suspended to 2 mg of protein per ml in 2 mM Tris (pH 7.4) containing 10 mM NaCl. Samples of this suspension were adjusted to (i) 0.35 M NaCl, (ii) 1 M NaCl, (iii) 3 M KCI, or (iv) 0.75 mM EDTA. After incubation on ice for 30 min, the suspensions were centrifuged (10 min, 13,000 x g), and the supernatant and pellet fractions were normalized to the same volume. Samples of each supernatant and pellet fraction were then analyzed by SDS-PAGE and immunoblotting as described above. In parallel experiments, duplicates of each suspension (i through iv) were adjusted to pH 8 (31) . Furthermore, preliminary experiments suggested that the MAb had antimycoplasma activity in a metabolic inhibition assay, in the presence of complement (31) . To further define the mechanism of MAb action, the mycoplasmacidal activity of MAb to p23/17 was assessed by incubating the MAb with M. hyorhinis GDL in the presence or absence of complement and subsequently determining the loss of viable organisms. Anti-p23/17 MAb was capable of reducing CFU by 75% during a 2-h incubation in the presence of active guinea pig complement (Fig. 1, bars A and E ). An unrelated, control IgM(K) MAb failed to reduce colony numbers in the presence of complement (Fig. 1, bar B) , as did other MAbs to surface antigens (31, 32) of this organism (data not shown). Exclusion or heat inactivation of complement abrogated the mycoplasmacidal effect of anti-p23/17 ( investigated the nature of the association of the protein(s) with the mycoplasma membrane. TX-114 phase partitioning allowed a simple and rapid means of characterizing this interaction. Figure 2 illustrates the ability of this technique to separate components of whole mycoplasmas into physically distinct classes of proteins. Whole mycoplasma stocks were phase partitioned with TX-114 as described in Materials and Methods, and the separated phases were subjected to SDS-PAGE for polypeptide analysis with the sensitive silver stain technique to monitor distribution of mycoplasma components. A majority of the total mycoplasma polypeptides (Fig. 2, lane B) partitioned into the aqueous phase after detergent phase fractionation (lane D). However, a smaller, distinct subset of the total polypeptides partitioned exclusively into the TX-114 phase (lane C). Since molecules containing extensive hydrophobic characteristics selectively partition into this TX-114 phase (18) , the polypeptides in lane C could be classified as integral membrane components likely to interact directly with the single, limiting plasma membrane of the mycoplasma. Unique polypeptide components were also visible in the insoluble pellet fraction obtained from the initial TX-114 solubilization (data not shown); in other systems (1, 18) these components represent cellular material unable to form mixed micelles with relatively mild, nonionic detergents such as TX-114. This fraction was not characterized further in the present study.
To evaluate the partitioning characteristics of specific mycoplasma antigens, TX-114 phase fractionated organisms were separated by SDS-PAGE as in Fig. 2 , and immunoblots were prepared and stained with MAbs specific for selected mycoplasma protein antigens (Fig. 3) . In addition to the MAb to p23/17 surface antigen, MAbs to two other proteins (p38 and p51) of M. hyorhinis (31, 32) immunoblots. Neither of the latter two MAbs bound to surface epitopes of the organism (31, 32). Interestingly, both p23 and p17 molecules recognized by the surface-binding MAb were shown to partition exclusively into the TX-114 phase (Fig. 3, lane B) . In addition, the relative staining intensity of p23 to p17 is similar in both total mycoplasma preparations (lane A) and TX-114 phase proteins (lane B). In both cases, p23 bound significantly greater quantities of MAb than p17. In contrast to p23 and p17, non-surface antigens p51 and p38 partitioned primarily into the aqueous phase (Fig. 3, lane C Freeze-thaw disrupted mycoplasms were treated with trypsin and subjected to SDS-PAGE and immunoblot analysis; MAb to p23/17 was used to immunostain the protein blots, thereby identifying only those molecules which retain this epitope. In a series of experiments with graded trypsin digestion, multiple trypsin-sensitive sites were detected in the p23 molecule; as trypsin digestion proceeded, the 23-kDa immunoreactive protein was progressively degraded through intermediate products to a limit 18-kDa immunoreactive fragment, whereas p17 was not affected by trypsin treatment (data not shown). Analysis of these antigenic fragments by TX-114 phase partitioning revealed that p18, the limit fragment of trypsin-digested p23, is hydrophobic (Fig. 4, lane B) . The trypsin incubation conditions for the material shown in Fig. 4 were adjusted so that p23 had not yet been completely degraded to p18; in addition, the amount of protein separated by SDS-PAGE was great enough to easily distinguish the less abundant p17 component after immunoblotting (as in Fig. 3 ). All immunoreactive components partitioned efficiently into the TX-114 phase (Fig. 4, lane B) , indicating that p23 and its epitope-bearing trypsin fragments were all hydrophobic. The smaller p17 component, which is not affected by trypsin treatment, also partitioned into the TX-114 phase, consistent with the result shown in Fig. 3 . These results indicate that the epitope responsible for binding of MAb to p23/17 exists both on a 23-kDa protein and a related, 18-kDa trypsin-resistant fragment and on a separate, trypsininsensitive, 17-kDa protein.
To further assess the stability of the interaction of p23/17 components with the mycoplasma membrane, either untreated or trypsin-treated mycoplasmas were incubated under conditions where electrostatically bound membrane components were likely to be released. Changes in ionic strength and pH, as well as the presence of EDTA at low ionic strength (see Materials and Methods), all failed to release p23/17 components from mycoplasmas (data not shown), strongly suggesting that the hydrophobic characteristics of these molecules identified by phase partitioning were responsible for their stable association with the mycoplasma membrane.
Localization and anchorage of the epitope-containing trypsin fragment p18 at the outer surface of the mycoplasma membrane. Freshly harvested, intact mycoplasmas were treated with trypsin to determine the topology of the trypsin-A B C Fig. 4 resulted from proteolysis at the internal surface of the mycoplasma membrane, those sites would be protected during trypsin treatment of intact cells; however, if trypsin-sensitive sites were on the external surface of the membrane, p23 might be cleaved to its limit tryptic fragment, p18. In addition, by monitoring both the appearance of p18 and its association with or release from intact cells, possible membrane anchorage sites of the parent p23 antigen might be directly mapped onto this proteolytic peptide. After incubation of intact mycoplasmas with trypsin as described in Materials and Methods, the organisms were separated from the incubation medium by centrifugation, and the supernatant and suspended cell pellet were analyzed by SDS-PAGE and immunoblotting to identify components immunoreactive with the MAb to p23/17 (Fig. 5) . The amount of protein applied to SDS-PAGE was adjusted to allow immunological visualization only of p23 and its proteolytic fragments (the less abundant, trypsin-resistant p17 was not detectable under these conditions). Incubation of intact mycoplasmas in buffer without trypsin yielded the native p23, which was exclusively associated with cells (Fig.  5, lanes A and B) . The addition of trypsin to the incubation medium resulted in the formation of the p18 immunoreactive peptide and the complete disappearance of the p23 protein.
Moreover, the p18 fragment remained quantitatively associated with cells and was not released into the supernatant (Fig. 5, lanes C and D) . In contrast, staining of blots with MAbs to antigens p38 and pS1 showed these two proteins to be unaltered by trypsin treatment (data not shown), thereby supporting the selective cleavage of surface proteins in this experiment and further confirming that these two hydrophilic components were internal mycoplasma constituents.
Since the p23 molecule was converted entirely to its limit tryptic fragment under these conditions, these results indicate that the trypsin sites on p23 that were detected in disrupted mycoplasmas (Fig. 4) are localized on the outer surface of the mycoplasma membrane. Moreover, the failure of the p18 product to be released from cells after cleavage directly established the presence on this fragment of regions capable of anchoring the entire p23 protein in the plasma membrane of these organisms.
DISCUSSION
The antigenic fine structure of an integral membrane protein of M. hyorhinis has been elucidated in this study by the combined use of a mycoplasmacidal MAb and a novel application of a detergent phase partitioning system employing TX-114 (1). The binding of the MAb to an epitope on the mycoplasma surface (31) has been shown to mediate direct damage to the membrane by a complement-dependent pathway. The proximity of the epitope to the plasma membrane implied by this observation has been further substantiated by demonstrating the selective and efficient partitioning of the epitope-bearing p23 and p17 proteins into the hydrophobic TX-114 detergent phase. The selective segregation of hydrophobic proteins by their ability to form detergent micelles in this system enabled a rapid identification of the p23/17 protein as an integral membrane protein. Detergent phase partitioning has gained wide acceptance in selectively fractionating proteins associated with a number of membrane systems (recently reviewed in reference 18). Two particular advantages, however, underscore the unique applicability of this technique to the study of mycoplasma membrane proteins. First, unlike eubacteria and eucaryotes, mycoplasmas have only a single plasma membrane system which is essentially responsible for all communication of these organisms with their external environment. As a result, proteins identified during phase partitioning by their intrinsic property of hydrophobicity are selected as components likely to be associated with this single membrane system. It is therefore an efficient method to focus on a group of mycoplasma components having probable roles in important membrane functions. Second, it is generally established that with the notable exception of acholeplasmas, most mycoplasmas yield membrane preparations by standard disruption procedures that are significantly contaminated with intracellular and extracellular macromolecules (19) . The use of TX-114 phase partitioning is perhaps ideally suited, therefore, for the segregation of mycoplasma membrane proteins from these contaminants, as shown by our characterization of the p23/17 membrane antigen.
Because of the possibility raised by this study that the p23/17 antigen could be a target of a mycoplasmacidal immune response in vivo, further delineation of the orientation and molecular location of the epitope was sought. The p23 molecule was established to be exposed at the mycoplasma surface, since it was susceptible on intact organisms to the action of trypsin, which cleaved it to a limit p18 fragment that remained associated with the organism.
The exact location and surface exposure of the less abundant p17 protein could not be established by this procedure, since it was insensitive to proteolytic cleavage by trypsin and to a number of other proteases (unpublished observation).
The association of the epitope-bearing p18 tryptic fragment with the mycoplasma membrane after enzymatic cleavage was established by its failure to be released into the supernatant (both spontaneously and under conditions fa-voring dissociation of extrinsic proteins) and by its marked hydrophobicity during phase partitioning of trypsin-treated organisms. This suggested that at least one strongly hydrophobic region of the parent p23 protein resided on this fragment along with the antigenic structure bound by the mycoplasmacidal MAb.
Neither the precise nature of the epitope nor the structure within this molecule mediating its hydrophobic membrane interaction could be directly determined by these experiments. In addition to a possible domain formed by hydrophobic amino acid sequences, an alternative means of membrane anchorage may be utilized by this molecule. It has been recently established that numerous membrane proteins in a variety of procaryotic and eucaryotic systems are modified by covalently attached lipids, which may act in some cases as the major means of membrane attachment (22, 23) . A number of similarly modified proteins have been reported in some mycoplasma species (5) (6) (7) 17) An additional feature of the antigenic structure defined by the MAb to p23/17 is its selective expression on only one of two strains of M. hyorhinis (31) . This species has been shown to express antigenic variation in serologic tests that measure inhibitory antibodies thought to be directed in part to surface antigens (12, 27) . Significantly, the MAb used in the present study defines precisely this type of antigenic variation and furthermore allows partial characterization of the surface membrane protein expressing this variation. It is not clear what structural or mechanistic features might cause the presence or absence of the specific epitope recognized by the MAb, although variable expression of the protein, altered protein processing or patterns of modification (including lipid acylation), or steric hinderance by other surface structures might all be invoked to explain this phenomenon. Tools for fuller analysis of structural and antigenic variation associated with this surface antigen have been established in the present study.
Finally, it is important to emphasize the value of the techniques and reagents developed in this study as a means of studying the structure and function of membrane proteins of any mycoplasma species. Efficient isolation of intrinsic membrane proteins by phase partitioning, reconstitution of these structures into liposomes, and monitoring of the expression, orientation and interaction of these components with specific MAbs may be particularly useful in investigating the functional roles of surface proteins in dictating the final outcome of the mycoplasma-host interaction, both in vitro and dunng mycoplasma infection in vivo.
